2021-01-17
Published Date
Construction
Industry
92
Pages
Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Ganciclovir market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market is expected to play significant role in the development of demand and improvement due to COVID-19..
Based on the type of product, the global Ganciclovir market segmented into
Injection
Oral
Based on the end-use, the global Ganciclovir market classified into
AIDS
Tube transplant
Malignant neoplasms
CMV Infection
Based on geography, the global Ganciclovir market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Roche
Bausch & Lomb
Fresenius Kabi
Luitpold
Huatai Pharmaceutical
Wuhan Hualong Bio-pharmaceutical
Luoxin
HUBEI KEYI
Tungshun Group
Tiantianming
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL GANCICLOVIR INDUSTRY
2.1 Summary about Ganciclovir Industry
2.2 Ganciclovir Market Trends
2.2.1 Ganciclovir Production & Consumption Trends
2.2.2 Ganciclovir Demand Structure Trends
2.3 Ganciclovir Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Injection
4.2.2 Oral
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 AIDS
4.3.2 Tube transplant
4.3.3 Malignant neoplasms
4.3.4 CMV Infection
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Injection
5.2.2 Oral
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 AIDS
5.3.2 Tube transplant
5.3.3 Malignant neoplasms
5.3.4 CMV Infection
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Injection
6.2.2 Oral
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 AIDS
6.3.2 Tube transplant
6.3.3 Malignant neoplasms
6.3.4 CMV Infection
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Injection
7.2.2 Oral
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 AIDS
7.3.2 Tube transplant
7.3.3 Malignant neoplasms
7.3.4 CMV Infection
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Injection
8.2.2 Oral
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 AIDS
8.3.2 Tube transplant
8.3.3 Malignant neoplasms
8.3.4 CMV Infection
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Injection
9.2.2 Oral
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 AIDS
9.3.2 Tube transplant
9.3.3 Malignant neoplasms
9.3.4 CMV Infection
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Roche
10.1.2 Bausch & Lomb
10.1.3 Fresenius Kabi
10.1.4 Luitpold
10.1.5 Huatai Pharmaceutical
10.1.6 Wuhan Hualong Bio-pharmaceutical
10.1.7 Luoxin
10.1.8 HUBEI KEYI
10.1.9 Tungshun Group
10.1.10 Tiantianming
10.2 Ganciclovir Sales Date of Major Players (2017-2020e)
10.2.1 Roche
10.2.2 Bausch & Lomb
10.2.3 Fresenius Kabi
10.2.4 Luitpold
10.2.5 Huatai Pharmaceutical
10.2.6 Wuhan Hualong Bio-pharmaceutical
10.2.7 Luoxin
10.2.8 HUBEI KEYI
10.2.9 Tungshun Group
10.2.10 Tiantianming
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
1.Table Ganciclovir Product Type Overview
2.Table Ganciclovir Product Type Market Share List
3.Table Ganciclovir Product Type of Major Players
4.Table Brief Introduction of Roche
5.Table Brief Introduction of Bausch & Lomb
6.Table Brief Introduction of Fresenius Kabi
7.Table Brief Introduction of Luitpold
8.Table Brief Introduction of Huatai Pharmaceutical
9.Table Brief Introduction of Wuhan Hualong Bio-pharmaceutical
10.Table Brief Introduction of Luoxin
11.Table Brief Introduction of HUBEI KEYI
12.Table Brief Introduction of Tungshun Group
13.Table Brief Introduction of Tiantianming
14.Table Products & Services of Roche
15.Table Products & Services of Bausch & Lomb
16.Table Products & Services of Fresenius Kabi
17.Table Products & Services of Luitpold
18.Table Products & Services of Huatai Pharmaceutical
19.Table Products & Services of Wuhan Hualong Bio-pharmaceutical
20.Table Products & Services of Luoxin
21.Table Products & Services of HUBEI KEYI
22.Table Products & Services of Tungshun Group
23.Table Products & Services of Tiantianming
24.Table Market Distribution of Major Players
25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
27.Table Global Ganciclovir Market Forecast (Million USD) by Region 2021f-2026f
28.Table Global Ganciclovir Market Forecast (Million USD) Share by Region 2021f-2026f
29.Table Global Ganciclovir Market Forecast (Million USD) by Demand 2021f-2026f
30.Table Global Ganciclovir Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Ganciclovir Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Ganciclovir Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Ganciclovir Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Ganciclovir Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Ganciclovir Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Ganciclovir Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Ganciclovir Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure AIDS Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Tube transplant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Malignant neoplasms Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure CMV Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure AIDS Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Tube transplant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Malignant neoplasms Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure CMV Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure AIDS Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Tube transplant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Malignant neoplasms Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure CMV Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure AIDS Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Tube transplant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Malignant neoplasms Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure CMV Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure AIDS Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Tube transplant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Malignant neoplasms Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure CMV Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure AIDS Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Tube transplant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Malignant neoplasms Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure CMV Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Ganciclovir Sales Revenue (Million USD) of Roche 2017-2020e
72.Figure Ganciclovir Sales Revenue (Million USD) of Bausch & Lomb 2017-2020e
73.Figure Ganciclovir Sales Revenue (Million USD) of Fresenius Kabi 2017-2020e
74.Figure Ganciclovir Sales Revenue (Million USD) of Luitpold 2017-2020e
75.Figure Ganciclovir Sales Revenue (Million USD) of Huatai Pharmaceutical 2017-2020e
76.Figure Ganciclovir Sales Revenue (Million USD) of Wuhan Hualong Bio-pharmaceutical 2017-2020e
77.Figure Ganciclovir Sales Revenue (Million USD) of Luoxin 2017-2020e
78.Figure Ganciclovir Sales Revenue (Million USD) of HUBEI KEYI 2017-